Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Brain Neoplasms 92Glioblastoma 79Glioma 74Neuroblastoma 30Neoplasms 21Neurofibromatosis 1 20Astrocytoma 20Central Nervous System Neoplasms 19Sarcoma 17Melanoma 17Medulloblastoma 17Ependymoma 17Carcinoma, Non-Small-Cell Lung 15Meningioma 14Rhabdoid Tumor 13Osteosarcoma 13Wilms Tumor 12Sarcoma, Ewing 12Rhabdomyosarcoma 12Breast Neoplasms 12Neurofibroma, Plexiform 11Hepatoblastoma 11Neuroectodermal Tumors, Primitive, Peripheral 9Lymphoma, Non-Hodgkin 9Lung Neoplasms 9Histiocytosis, Langerhans-Cell 9Diffuse Intrinsic Pontine Glioma 9Recurrence 8Pheochromocytoma 8Pancreatic Neoplasms 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Amyotrophic Lateral Sclerosis × CNS × 30 days × Clear all
NCT07595666 2026-05-19

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Universitaire Ziekenhuizen KU Leuven

Phase NA Enrolling by invitation
1,600 enrolled
CNSEndocrineHead & Neck

Amyotrophic Lateral Sclerosis, Brain Neoplasms, Dementia, Epilepsy, Head and Neck Neoplasms, Movement Disorders, Neuroblastoma, Parathyroid Neoplasms, Parkinson Disease, Pituitary Neoplasms, Lewy Body Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡